-
Webinar: Prostate Cancer and Making Sense of nmCRPC Treatment Options
Webinar: Prostate Cancer and Making Sense of nmCRPC Treatment Options
Episode 1 of 3 in Your Prostate Cancer Questions Answered. In 2018, patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) were watching and waiting. Two years later there are three novel androgen receptor inhibitors available. But more options mean more questions for doctors and for patients. In this first installment of our prostate cancer Answers Now series, we’ll explore these […]